The University of South Florida and the University of Florida convened a Microbiome Joint Workshop at USF Health on May 28, with research presentations by basic scientists and clinician scientists from both universities. It was an important first step in working together to unravel how different microorganisms living in our guts, on our skin, and pretty much everywhere influence human health and disease – and might be beneficially exploited for new therapies.
The USF and UF researchers covered a broad range of topics, including effects of the microbiome’s distinct compositions on preterm infant growth and development, on responses to cancer immunotherapy, and chronic rejection of lung transplants, as well as the link between the gut microbiome and the brain in hypertension. Also presented was UF Health’s use of fecal microbiota transplants to treat antibiotic-resistant, recurring Clostridium difficile infection and its studies to restore the balance of gut bacteria in patients with C. diff.
Read more at USF Health News